Elan Corporation PLC (NYSE:ELN)
| 11.67 Data as of May 17 |  +0.08 / +0.69%Today’s Change | 9.37 Today|||52-Week Range 14.63 | +14.30% Year-to-Date |
Latest ELN News | Press Releases
| Keeping an Eye on the Pros May 16 / TheStreet.com | Stock Futures Lower Ahead of Retail Sales May 13 / TheStreet.com |
| Keeping an Eye on the Pros May 15 / TheStreet.com | Stocks to Watch: Elan, Theravance, Take-Two May 13 / TheStreet.com |
| Elan in Royalty Deal with THRX - Analyst Blog May 14 / Zacks.com | Dendreon Narrows 1Q Loss - Analyst Blog May 10 / Zacks.com |
| Spectrum Pharma Reports 1Q Loss - Analyst Blog May 14 / Zacks.com | Santarus Beats on Earnings and Revs - Analyst Blog May 08 / Zacks.com |
| Morning Briefing: 10 Things You Should Know May 13 / TheStreet.com | Positive Data on Forest Combo Drug - Analyst Blog May 07 / Zacks.com |
Today’s Trading
| Previous close | 11.59 |
| Today’s open | 11.58 |
| Day’s range | 11.48 - 11.68 |
| Volume | 3,618,571 |
| Average volume (3 months) | 5,707,038 |
| Market cap | $6.0B |
| Dividend yield | -- |
Data as of 4:05pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +16.02% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +26.50% |
| Revenue growth (last year) | -99.97% |
| P/E ratio | NM |
| Price/Sales | 30,253.34 |
| Price/Book | 12.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HSPHospira Inc | +0.02 | +0.06% |
| PCYCPharmacyclics Inc | +0.97 | +1.16% |
| RDYDr.Reddy's Laborator... | -0.61 | -1.58% |
| ONXXOnyx Pharmaceuticals... | +0.30 | +0.31% |
Data as of 4:02pm ET, 05/17/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $199.9K |
| Annual profit (last year) | -$97.4M |
| Net profit margin | -181,950.00% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director G. Kelly Martin |
Chief Operating Officer Hans-Peter Hasler |
Corporate headquarters Dublin, Dublin |
Forecasts
